Decreased prevalence and intensity of Loa loa infection in a community treated with ivermectin every three months for two years

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 4, 1996, Pages 429-430

  Ranque, S ^a   Garcia, A ^a   Boussinesq, M ^a   Gardon, J ^a   Kamgno, J ^a   Chippaux, J P ^a,b  

^a Institut de Recherche pour le Developpement Cameroon   (Cameroon)

^b Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

Author keywords

Intensity; Ivermectin; Loa loa; Loiasis; Prevalence

Indexed keywords

IVERMECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAMEROON; CHILD; DISEASE SEVERITY; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; FILARIASIS; HUMAN; INFANT; LOA LOA; MALE; NEWBORN; PARASITE PREVALENCE;

LOA LOA;

EID: 0029789606     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90535-0     Document Type: Article

References (13)

1. Beesley, W. N. & Crewe, W. (1963). The bionomics of Chysops silacea Austen, 1907. II.-The biting rhythm and dispersal in rain forest. Annals of Tropical Medicine and Parasitology, 57, 191-203.
2. Carme, B., Ebiliki, B., Mbitsi, A. & Copin, N. (1991). Essai thérapeutique de l'ivermectine au cours de la loase à moyenne et forte microfilarémie. Annales de la Société Belge de Médecine Tropicale, 71, 47-50.
3. Chippaux, J.-P., Ernould, J.-C., Gardon, J., Gardon-Wendel, N., Chandre, F. & Barberi, N. (1992). Ivermectin treatment of loiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 289.
4. Chippaux, J.-P., Garcia, A., Ranque, S., Schneider, D., Boussinesq, M., Cot, S., Le Hesran, J.-Y. & Cot, M. (1993). Adverse reactions following ivermectin treatment in hyperendemic loiasis area. American Journal of Tropical Medicine and Hygiene, 49, supplement, 161.
5. Chippaux, J.-P., Bouchité, B., Demanou, M., Morlais, I. & Legoff, G. (in press). Study of the dispersal and the density of loiasis vectors Chrysops dimidiata in rain forest of Southern Cameroon. Medical and Veterinary Entomology.
6. Ducorps, M., Gardon-Wendel, N., Ranque, S., Ndong, W., Boussinesq, M., Gardon, J. Schneider, D. & Chippaux, J.-P. (1995). Effets secondaires du traitement de la loase hypermicrofilarémique par l'ivermectine. Bulletin de la Société de Pathologie Exotique, 88, 105-112.
7. Fain, A. (1981). Épidémiologie et pathologie de la loase. Annales de la Société Belge de Médecine Tropicale, 61, 277-285.
8. Garcia, A., Abel, L., Cot, M., Ranque, S., Richard, P., Boussinesq, M. & Chippaux, J.-P. (1995). Longitudinal survey of Loa loa filariasis in south Cameroon: long term durability and factors influencing individual microfilarial status. American Journal of Tropical Medicine and Hygiene, 52, 370-375.
9. Hawking, F. (1977). The distribution of human filariasis throughout the world. Part III. Africa. Tropical Diseases Bulletin, 74, 649-679.
10. Martin-Prével, Y., Cosnefroy, J.-Y., Ngari, P. & Pinder, M. (1993). Reduction of microfilaraemia with single high-dose of ivermectin in loiasis. Lancet, 342, 442.
11. Noireau, F. (1990). Possibilités actuelles de lutte contre la filariose à Loa loa. Annales de la Société Belge de Médecine Tropicale, 70, 167-172.
12. Pinder, M. (1988). Loa loa. A neglected filaria. Parasitology Today, 4, 279-284.
13. Rhodain, F. (1980). Hypothèses concernant l'écologie dynamique des infections à Loa. Bulletin de la Société de Pathologie Exotique, 73, 182-191.